PREDICTIVE VALUE OF EARLY PASI RESPONSE TO TILDRAKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS

PREDICTIVE VALUE OF EARLY PASI RESPONSE TO TILDRAKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS Meeting Abstract

sustainable development goals

SDG 03: Good Health and Well-being

publication date

May 1, 2019

webpage

Web of Science

published in

VALUE IN HEALTH Journal

start page

S53

end page

S53

volume

22